Cilazapril

Cilazapril
Names
IUPAC name
(4S,7S)-7-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-6-oxo-1,2,3,4,7,8,9,10-octahydropyridazino[1,2-a]diazepine-4-carboxylic acid
Identifiers
88768-40-5 N
ChEMBL ChEMBL515606 N
ChemSpider 50831 N
DrugBank DB01340 YesY
6459
Jmol interactive 3D Image
KEGG D07699 YesY
PubChem 56330
40467985 (1R,9S)-(2S)-butylamino isomer
UNII 8Q9454114Q N
Properties
C22H31N3O5
Molar mass 417.51 g·mol−1
log P 2.212
Acidity (pKa) 2.285
Basicity (pKb) 11.712
Pharmacology
ATC code C09AA08
Legal status
  • UK: POM (Prescription only)
Oral
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
N verify (what is YesYN ?)
Infobox references

Cilazapril is an angiotensin-converting enzyme inhibitor (ACE inhibitor) used for the treatment of hypertension and congestive heart failure.[1][2] It is branded as Inhibace in Canada and other countries, Vascace and Dynorm in a number of European countries, among many other names. None of these is available in the United States as of May 2010.[3]

Of the eight possible stereoisomers, only the all-(S)-form is medically viable.

Synthesis

Cilazapril synthesis[4]

See also

References

  1. Szucs, T. (1991). "Cilazapril. A review". Drugs. 41 Suppl 1: 18–24. doi:10.2165/00003495-199100411-00005. PMID 1712267.
  2. Jasek, W, ed. (2007). Austria-Codex (in German) (2007/2008 ed.). Vienna: Österreichischer Apothekerverlag. ISBN 978-3-85200-181-4.
  3. Drugs.com: Cilazapril
  4. Attwood, M. R.; Hassall, C. H.; Kröhn, A.; Lawton, G.; Redshaw, S. (1986). "The design and synthesis of the Angiotensin Converting Enzyme inhibitor Cilazapril and related bicyclic compounds". Journal of the Chemical Society, Perkin Transactions 1: 1011. doi:10.1039/P19860001011.
This article is issued from Wikipedia - version of the Monday, December 14, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.